367 related articles for article (PubMed ID: 26024352)
1. Amyloid β Oligomeric Species Present in the Lag Phase of Amyloid Formation.
Wolff M; Unuchek D; Zhang B; Gordeliy V; Willbold D; Nagel-Steger L
PLoS One; 2015; 10(5):e0127865. PubMed ID: 26024352
[TBL] [Abstract][Full Text] [Related]
2. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
Ferrera D; Mazzaro N; Canale C; Gasparini L
Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
[TBL] [Abstract][Full Text] [Related]
3. Engineering of a peptide probe for β-amyloid aggregates.
Aoraha E; Candreva J; Kim JR
Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
[TBL] [Abstract][Full Text] [Related]
4. α-synuclein-assisted oligomerization of β-amyloid (1-42).
Chau E; Kim JR
Arch Biochem Biophys; 2022 Mar; 717():109120. PubMed ID: 35041853
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of Inter-Molecular Interactions Between Single Aβ
Feng L; Watanabe H; Molino P; Wallace GG; Phung SL; Uchihashi T; Higgins MJ
J Mol Biol; 2019 Jul; 431(15):2687-2699. PubMed ID: 31075274
[TBL] [Abstract][Full Text] [Related]
6. Internalisation and toxicity of amyloid-β 1-42 are influenced by its conformation and assembly state rather than size.
Vadukul DM; Maina M; Franklin H; Nardecchia A; Serpell LC; Marshall KE
FEBS Lett; 2020 Nov; 594(21):3490-3503. PubMed ID: 32871611
[TBL] [Abstract][Full Text] [Related]
7. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
Chang YJ; Chen YR
FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
[TBL] [Abstract][Full Text] [Related]
8. Thioflavin T templates amyloid β(1-40) conformation and aggregation pathway.
Di Carlo MG; Minicozzi V; Foderà V; Militello V; Vetri V; Morante S; Leone M
Biophys Chem; 2015 Nov; 206():1-11. PubMed ID: 26100600
[TBL] [Abstract][Full Text] [Related]
9. Rapid α-oligomer formation mediated by the Aβ C terminus initiates an amyloid assembly pathway.
Misra P; Kodali R; Chemuru S; Kar K; Wetzel R
Nat Commun; 2016 Aug; 7():12419. PubMed ID: 27546208
[TBL] [Abstract][Full Text] [Related]
10. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
Nguyen P; Derreumaux P
Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
[TBL] [Abstract][Full Text] [Related]
11. Simulations on the dual effects of flavonoids as suppressors of Aβ42 fibrillogenesis and destabilizers of mature fibrils.
Gargari SA; Barzegar A
Sci Rep; 2020 Oct; 10(1):16636. PubMed ID: 33024142
[TBL] [Abstract][Full Text] [Related]
12. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
13. Aβ42 pentamers/hexamers are the smallest detectable oligomers in solution.
Wolff M; Zhang-Haagen B; Decker C; Barz B; Schneider M; Biehl R; Radulescu A; Strodel B; Willbold D; Nagel-Steger L
Sci Rep; 2017 May; 7(1):2493. PubMed ID: 28559586
[TBL] [Abstract][Full Text] [Related]
14. A mimotope of Aβ oligomers may also behave as a β-sheet inhibitor.
Zhang YX; Wang SW; Lu S; Zhang LX; Liu DQ; Ji M; Wang WY; Liu RT
FEBS Lett; 2017 Nov; 591(21):3615-3624. PubMed ID: 28976547
[TBL] [Abstract][Full Text] [Related]
15. High order W02-reactive stable oligomers of amyloid-β are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-β monomer.
Robb E; Perez K; Hung LW; Masters CL; Barnham KJ; Cherny RA; Bush AI; Adlard PA; Finkelstein DI
J Alzheimers Dis; 2015; 44(1):69-78. PubMed ID: 25182735
[TBL] [Abstract][Full Text] [Related]
16. Novel antibody against oligomeric amyloid-β: Insight into factors for effectively reducing the aggregation and cytotoxicity of amyloid-β aggregates.
Zhang X; Huai Y; Cai J; Song C; Zhang Y
Int Immunopharmacol; 2019 Feb; 67():176-185. PubMed ID: 30553911
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation.
Feng Y; Wang XP; Yang SG; Wang YJ; Zhang X; Du XT; Sun XX; Zhao M; Huang L; Liu RT
Neurotoxicology; 2009 Nov; 30(6):986-95. PubMed ID: 19744518
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of amyloid-β aggregation in Alzheimer's disease.
Wang Q; Yu X; Li L; Zheng J
Curr Pharm Des; 2014; 20(8):1223-43. PubMed ID: 23713775
[TBL] [Abstract][Full Text] [Related]
19. Medicinal Chemistry Focusing on Aggregation of Amyloid-β.
Sohma Y
Chem Pharm Bull (Tokyo); 2016; 64(1):1-7. PubMed ID: 26726739
[TBL] [Abstract][Full Text] [Related]
20. Kinetic Insights into Zn
Guo J; Yu L; Sun Y; Dong X
J Phys Chem B; 2017 Apr; 121(16):3909-3917. PubMed ID: 28378589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
